$27.01
Today
as of Sep 11, 16:56 ET
Last 30 days
Recent Press Releases & News
Yarrow Bioscience Announces Pricing of $150 Million Underwritten Public Offering
Yarrow Bioscience Launches Public Offering of Common Stock
Yarrow Bioscience Announces Proposed Underwritten Public Offering
Overview
52-week range
$15
$47
38% of range
Avg surprise (last 1)
+43.5%
Avg reaction (last 0)
—
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-3.51 | — | — | — | — | financials |
| Thu Aug 14, 2025 | Jun/2025 | $-0.13 | $-0.23 | +43.5% | — | — | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.29 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.22 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.15 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-2.01 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-3.09 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-1.74 | — | — | — | — | financials |
| Fri Sep 30, 2022 | Sep 2022 | $-2.94 | — | — | — | — | financials |
| Thu Jun 30, 2022 | Jun 2022 | $-2.63 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Dec 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $97,000 | — | $69,000 | — | $121,000 | $198,000 | $98,000 | $114,000 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-3M | — | $-8M | — | $-13M | $-10M | $-7M | $-6M |
| Net income | $-3M | — | $-6M | — | $-12M | $-9M | $-6M | $-7M |
| EPS (diluted) | $-3.51 | — | $-6.73 | — | $-0.29 | $-0.22 | $-0.15 | $-2.01 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Dec 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $23M | $24M | $22M | $28M | $16M | $30M | $19M | $15M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $24M | $30M | $44M | $55M | $74M | $84M | $90M | $18M |
| Total assets | $24M | $30M | $45M | $56M | $76M | $87M | $92M | $19M |
| Long-term debt | $0 | — | $0 | $0 | $0 | $0 | $0 | $0 |
| Total liabilities | $2M | $2M | $6M | $12M | $13M | $12M | $8M | $8M |
| Total equity | $22M | $28M | $39M | $44M | $64M | $75M | $83M | $12M |
Implied volatility — last 90 days
No IV snapshots yet for YARW.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.